High-Dose Antithrombin III in Severe SepsisBrian Warren, Alain Eid, Pierre Singer et al.|JAMA|2001Cited by 1.4k
High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: Efficacy and safety*Christian J. Wiedermann, Steven M. Opal, Johannes Hoffmann et al.|Critical Care Medicine|2006Cited by 188
Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial*Steven M. Opal, John P. Pribble, Jean-François Dhainaut et al.|Critical Care Medicine|2004Cited by 145
Benefit/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparinJohannes Hoffmann, Christian J. Wiedermann, Mathias Juers et al.|Thrombosis and Haemostasis|2006Cited by 85